Chairs and Faculty
November 16, 2026
8:00 AM - 12:20 PM PT (9:00 AM - 1:20 PM MT; 10:00 AM - 2:20 PM CT; 11:00 AM - 3:20 PM ET)Last Modified:
Program Description
This virtual course will provide a practical, case-informed review of key primary care considerations for clinicians caring for people with HIV. The course will focus on common and emerging issues encountered in HIV primary care, including aging, vaccinations, cancer screening, cardiovascular risk assessment, kidney disease, hypertension, metabolic disease, mental health, and substance use disorders.
Through focused didactic presentations, interactive question-and-answer sessions, and case-based discussions, the course will help clinicians apply current guidance and pragmatic strategies in clinical care. Emphasis will be placed on what can be managed within HIV primary care, when specialty referral is appropriate, and how to use available resources and guidelines to support comprehensive care for people with HIV.
Needs Assessment
As people with HIV live longer, clinicians increasingly manage a broad range of primary care issues alongside HIV treatment. Advances in the prevention, diagnosis, and management of chronic conditions such as cardiovascular disease, diabetes, kidney disease, mental health disorders, and substance use disorders require ongoing clinician education to ensure high-quality patient care. Clinicians need actionable, up-to-date strategies for evaluating and managing these conditions in HIV primary care, including guidance on emerging therapies, prevention and screening recommendations, and appropriate referrals to specialists. This course will address these needs through focused presentations and case-based discussions designed to support practical decision-making and improve comprehensive care for people with HIV.
Learning Objectives
After participating in the activity, learners will be able to:
- List key primary care considerations for people with HIV, including aging, vaccinations, cancer screening, and cardiovascular risk assessment
- Evaluate chronic kidney disease and hypertension in people with HIV
- Manage metabolic disease in people with HIV, including diabetes, dyslipidemia, obesity, and cardiovascular risk reduction
- Identify common mental health and substance use disorders encountered in HIV care and describe indicators for referral to specialty care
- Address common clinical challenges in older adults with HIV, including menopause, bone health, frailty, cognitive concerns, and polypharmacy
Preliminary Topics
- Primary care priorities for people with HIV, including aging, vaccinations, cancer screening, and cardiovascular risk assessment
- Evaluation and management of chronic kidney disease and hypertension in people with HIV
- Metabolic disease in HIV, including diabetes, dyslipidemia, obesity, and cardiovascular risk reduction
- Management of mental health and substance use disorders in HIV care
- Cases in aging with HIV: practical management of common clinical challenges, including menopause, bone health, frailty, cognitive concerns, and polypharmacy
Conflicts of Interest
In the interest of maintaining the independence of its continuing medical education (CME) activities, the International Antiviral Society–USA (IAS–USA) requires all persons with control of educational content (eg, faculty, Scientific Leadership Board, Governance Board, and program planner) to disclose any financial relationships with ineligible companies (previously defined as “commercial interests”) that they have had within the past 24 months. Any real or apparent conflicts of interest of those parties are resolved and mitigated prior to the CME activity being delivered. Individuals who refuse to disclose financial interests may not participate in IAS–USA CME activities.
The Accreditation Council for Continuing Medical Education (ACCME) defines ineligible companies as “those whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.”
IAS–USA will identify and resolve ahead of time any possible conflicts of interest that may influence CME activities with regard to exposition or conclusion. Information about financial relationships with ineligible companies for the presenters and planners/reviewers will be available in the esyllabus and in the slides prior to the presentation of educational content.
Registration
Who Should Attend
This course is designed for physicians who are actively involved in the medical care of people with HIV infection and:
- Have a solid, working knowledge of HIV disease management
- Provide comprehensive or specialty care for patients with HIV infection
This activity is also relevant to nurse practitioners, registered nurses, physician assistants, registered pharmacists, and other health professionals.
Representatives and employees of commercial companies (eg, pharmaceutical, diagnostic, medical products, advertising, insurance, investment, and communications firms) must contact the IAS–USA regarding registration procedures.
Cancellation Policy
Cancellation requests must be made 7 or more days before the date of an activity to receive a refund minus a $15 administrative fee. Any requests made within 6 days before the course will not be refunded. Please note: registration substitutions are not permitted.
Continuing Education Credits
CME Credits
The International Antiviral Society–USA (IAS–USA) is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The IAS–USA designates this live activity for a maximum of 4.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
ABIM MOC Points
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 4.0 MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit
Nursing Credits
Educational Review Systems is an approved approver of continuing nursing education by the ASNA, an accredited approver by the American Nurses Credentialing Center’s Commission on Accreditation. Provider # 5-115. This program is approved for 4 hours of continuing nursing education.
Educational Review Systems is also approved for nursing continuing education by the state of California (Provider # 14692), the state of Florida and the District of Columbia.
This program is approved for 4 hours of pharmacotherapy credit.
Pharmacy Credits
Educational Review Systems is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education. Participants of the session who complete the evaluation and provide accurate NABP e-Profile information will have their credit for 4 contact hours (0.4 CEU) submitted to CPE Monitor as early as 14 days after the event and no later than 60 days after the event. Please know that if accurate e-Profile information is not provided within 60 days of the event, credit cannot be claimed after that time. The participant is accountable for verifying the accurate posting of CE credit to their CPE Monitor account within 60 days.
UAN # 0761-9999-26-083-L02-P
Grant Support
This activity is part of the IAS–USA national educational effort that is funded, in part, by charitable contributions from ineligible companies. Per IAS–USA policy, any effort that uses grants from ineligible companies must receive grants from several companies with competing products. Funds are pooled and distributed to activities at the sole discretion of the IAS–USA. Grantors have no input into any activity, including its content, development, or selection of topics or speakers. Generous support for this activity has been received from the following contributors.
Platinum Supporters
Gilead Sciences, Inc
Merck & Co, Inc
ViiV Healthcare
Additional Supporter
Hologic, Inc
Frequently Asked Questions
View our list of FAQs about attending a webinar.
Further Questions?
Please contact the registration department at registration@iasusa.org or 415-544-9400.






